Prevalence and invasiveness of community-acquired methicillin-resistant Staphylococcus aureus: A meta-analysis

被引:19
|
作者
Li, Shipeng [1 ]
Li, Juan [1 ]
Qiao, Yanhong [1 ]
Ning, Xue [1 ]
Zeng, Ting [1 ]
Shen, Xuzhuang [1 ]
机构
[1] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Beijing 100045, Peoples R China
基金
中国国家自然科学基金;
关键词
Community-acquired methicillin-resistant Staphylococcus aureus; invasive infection; virulence; MOLECULAR EPIDEMIOLOGY; CLINICAL-FEATURES; RISK-FACTORS; INFECTIONS; CHILDREN; MRSA; EMERGENCE; HOSPITALS; DENMARK; SYSTEM;
D O I
10.4103/0377-4929.138737
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Reports suggest that the prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) has increased, and that CA-MRSA is more virulent than healthcare-associated (HA)-MRSA. Aims: The aim of this study is to gain a better understanding of the invasiveness and prevalence of CA-MRSA in patients; we systematically reviewed the literature by conducting a meta-analysis. Materials and Methods: We searched the MEDLINE and PUBMED databases from the year these databases were established to January 2013. Results: The pooled CA-MRSA prevalence among 50,737 patients from 33 studies was 39.0% (range, 30.8-47.8%). The pooled CA-MRSA prevalence rates among pediatric and adult patients with MRSA infection were 50.2% (range, 37.5-62.8%) and 42.3% (range, 16.4-73.3%), respectively. The pooled CA-MRSA prevalence rates of MRSA-infected patients in Asia, Europe, and North America were 23.1% (range, 12.0-39.8%), 37.4% (range, 21.1-56.4%), and 47.4% (range, 35.8-59.4%), respectively. Using the random effects model, we determined that the pooled odds ratio of invasive infections in CA-and HA-MRSA was 0.30 (95% confidence interval: 0.08-1.10; P = 0.07, test for heterogeneity P < 0.00001). Conclusions: The prevalence of CA-MRSA in MRSA infection varied with area and population. No difference in the ability to cause invasive infections was found between CA-and HA-MRSA. This finding challenges the view that CA-MRSA is more virulent than HA-MRSA.
引用
收藏
页码:418 / 422
页数:5
相关论文
共 50 条
  • [1] Community-acquired methicillin-resistant Staphylococcus aureus:: A meta-analysis of prevalence and risk factors
    Salgado, CD
    Farr, BM
    Calfee, DP
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (02) : 131 - 139
  • [2] Prevalence of community-acquired methicillin-resistant Staphylococcus aureus
    Ficca, G.
    Chauvel, M.
    de Mouy, D.
    MEDECINE ET MALADIES INFECTIEUSES, 2006, 36 (04): : 207 - 212
  • [3] Community-acquired methicillin-resistant Staphylococcus aureus
    Gross-Schulman, S
    Dassey, D
    Mascola, L
    Anaya, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (05): : 421 - 422
  • [4] Community-acquired methicillin-resistant Staphylococcus aureus
    Bengualid, V
    Berger, J
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) : 466 - 466
  • [5] Community-acquired, Methicillin-resistant, Staphylococcus aureus
    Tong, S.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2010, 51 : A14 - A14
  • [6] Community-acquired methicillin-resistant Staphylococcus aureus
    Salgado, CD
    Farr, BM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (16): : 1960 - 1961
  • [7] Community-acquired methicillin-resistant Staphylococcus aureus
    Elston, Dirk M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (01) : 1 - 16
  • [8] Prevalence of Methicillin-Resistant Staphylococcus aureus as an Etiology of Community-Acquired Pneumonia
    Moran, Gregory J.
    Krishnadasan, Anusha
    Gorwitz, Rachel J.
    Fosheim, Greg E.
    Albrecht, Valerie
    Limbago, Brandi
    Talan, David A.
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (08) : 1126 - 1133
  • [9] Community-acquired methicillin-resistant Staphylococcus aureus:: Prevalence and risk factors
    Beam, Joel W.
    Buckley, Bernadette
    JOURNAL OF ATHLETIC TRAINING, 2006, 41 (03) : 337 - 340
  • [10] Methicillin-resistant Staphylococcus aureus in community-acquired meningitis
    von Specht, M.
    Gardella, N.
    Taghaferri, P.
    Gutkind, G.
    Mollerach, M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (04) : 267 - 269